Diagnosis and treatment of primary plasma cell leukemia / 肿瘤
Tumor
;
(12): 218-221, 2012.
Artículo
en Chino
| WPRIM
| ID: wpr-849100
ABSTRACT
Primary plasma cell leukemia (PPCL) is a rare, highly aggressive plasma cell disease characterized with a poor prognosis and a low response rate to conventional therapy. It occurs de novo in the absence of a prior history of plasma cell myeloma. Recently, the use of novel drugs such as bortezomib and the approaches such as stem cell transplantation may improve the outcomes of PPCL. This review summarizes the diagnosis and treatment of PPCL in order to provide reference information for clinical practice. Copyright© 2012 by TUMOR.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Tipo de estudio:
Estudio diagnóstico
/
Estudio pronóstico
Idioma:
Chino
Revista:
Tumor
Año:
2012
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS